amiodarone has been researched along with Sarcoidosis, Pulmonary in 2 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Sarcoidosis, Pulmonary: Sarcoidosis affecting predominantly the lungs, the site most frequently involved and most commonly causing morbidity and mortality in sarcoidosis. Pulmonary sarcoidosis is characterized by sharply circumscribed granulomas in the alveolar, bronchial, and vascular walls, composed of tightly packed cells derived from the mononuclear phagocyte system. The clinical symptoms when present are dyspnea upon exertion, nonproductive cough, and wheezing. (Cecil Textbook of Medicine, 19th ed, p431)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Cells were obtained from patients with idiopathic pulmonary fibrosis (n = 10), patients with sarcoidosis (n = 20), and patients receiving amiodarone without evidence of clinical lung disease (n = 10) as well as from normal volunteers (n = 8)." | 3.68 | Alveolar macrophage surface carbohydrate expression is altered in interstitial lung disease as determined by lectin-binding profiles. ( Auerbach, R; Meyer, KC; Powers, C; Rosenthal, N, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camus, P | 1 |
| Bonniaud, P | 1 |
| Fanton, A | 1 |
| Camus, C | 1 |
| Baudaun, N | 1 |
| Foucher, P | 1 |
| Meyer, KC | 1 |
| Powers, C | 1 |
| Rosenthal, N | 1 |
| Auerbach, R | 1 |
1 review available for amiodarone and Sarcoidosis, Pulmonary
| Article | Year |
|---|---|
Drug-induced and iatrogenic infiltrative lung disease.
Topics: Amiodarone; Anti-Arrhythmia Agents; Drug-Related Side Effects and Adverse Reactions; Humans; Iatroge | 2004 |
1 other study available for amiodarone and Sarcoidosis, Pulmonary
| Article | Year |
|---|---|
Alveolar macrophage surface carbohydrate expression is altered in interstitial lung disease as determined by lectin-binding profiles.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Binding, Competitive; Bronchoalveolar Lavage | 1993 |